A Method of Nodose Ganglia Injection in Sprague-Dawley Rat
November 25th, 2014
19.3K views
Afferent vagal signaling transmits important information to central nervous system from receptors located in organs of the abdomen and thorax. The nodose ganglia of vagus nerves contain many types of receptors that modulate vagal activity. This protocol describes a method of local injections of neurochemicals into the nodose ganglia.
Overview
This article presents a detailed protocol for performing local injections of neurochemicals into the nodose ganglia to investigate their effects on vagus nerve activity. The procedure involves surgical techniques to access the ganglia and precise injection methods to study physiological responses.
Key Study Components
Area of Science
- Neuroscience
- Physiology
- Neurochemistry
Background
- Afferent vagal signaling is crucial for transmitting information from abdominal and thoracic organs to the central nervous system.
- The nodose ganglia contain various receptors that modulate vagal activity.
- Understanding the modulation of vagus nerve activity can provide insights into physiological behaviors.
- Local neurochemical injections can help answer key questions in neuroscience.
Purpose of Study
- To investigate the effects of neurochemicals on vagus nerve activity.
- To refine techniques for local injections into the nodose ganglia.
- To explore the physiological and behavioral responses following neurochemical modulation.
Methods Used
- Conducting neck surgery to visualize the nodose ganglia and vagus nerves.
- Isolating and cleaning the nodose ganglia from connective tissues.
- Injecting neurochemicals and measuring physiological responses.
- Using precision syringes and monitoring respiratory signals during experiments.
Main Results
- Successful injection of neurochemicals into the nodose ganglia.
- Observation of apnea in rats following serotonin infusion.
- Demonstration of the technique's effectiveness in modulating vagus nerve activity.
- Insights into the relationship between neurochemical administration and physiological responses.
Conclusions
- The protocol provides a reliable method for studying vagus nerve modulation.
- Local injections can significantly influence physiological behaviors.
- This research contributes to a deeper understanding of vagal signaling mechanisms.
Frequently Asked Questions
What is the main goal of the study?
The main goal is to investigate the effects of neurochemicals on vagus nerve activity through local injections into the nodose ganglia.
What techniques are used in this protocol?
The protocol involves surgical techniques to access the nodose ganglia and precise injection methods for neurochemicals.
Why is the vagus nerve important?
The vagus nerve plays a crucial role in transmitting information from the body to the central nervous system, influencing various physiological functions.
What are the expected outcomes of the neurochemical injections?
The expected outcomes include changes in physiological behaviors, such as apnea, in response to neurochemical modulation.
How can this research contribute to neuroscience?
This research can enhance the understanding of vagal signaling and its implications for physiological and behavioral responses.
Executive Industry Relevance
This method enables precise interrogation of vagal afferent signaling by targeting nodose ganglion cell bodies, offering a reductionist approach to de-risk neurochemical target validation in autonomic neuroscience. By isolating ganglion-specific effects from central nervous system confounders, it supports mechanistic clarity in early discovery of therapeutics targeting vagal modulation for indications such as sleep apnea or gastrointestinal disorders. The technique provides a reproducible, low-cost platform for generating quantitative physiological readouts that inform go/no-go decisions in target selection pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables direct assessment of neurochemical effects on vagal afferent cell bodies to clarify target engagement and pathway specificity.
- Operational Value: Reduces mechanistic ambiguity by isolating peripheral ganglion activity from central nervous system contributions.
- Predictive Value: Supports target de-risking through observable physiological outputs like apnea onset, linked to vagal modulation.
Screening & Assay Development
- Scientific Value: Generates quantifiable respiratory response metrics (e.g., apnea duration >2.5 seconds) as a functional readout for neurochemical screening.
- Operational Value: Uses standardized surgical and infusion protocols to ensure reproducibility across experimental runs.
- Scalability: Requires only basic microsurgical tools and precision syringes, enabling adaptation in academic-industrial collaborative settings.
Translational & Preclinical Research
- Translational Relevance: Models human vagal afferent pathways involved in respiratory and gastrointestinal regulation, relevant to CNS-autonomic drug discovery.
- Preclinical Continuity: Bridges in vitro receptor screening with in vivo physiological validation via ganglion-specific neurochemical delivery.
- Risk Mitigation: Identifies neurochemicals with off-target vagal effects early, reducing late-stage attrition in autonomic drug development.
Pipeline & Workflow Integration
The method fits within early discovery workflows where target validation requires functional confirmation of neurochemical activity in native tissue contexts, preceding lead optimization and preclinical efficacy studies.
- Discovery Biology: Tests hypothalamic-brainstem axis modulation by isolating vagal ganglion responses to serotonergic and cannabinoid compounds.
- Screening: Establishes assay readiness through quantifiable apnea detection via piezo-electric strain gauge and amplifier software.
- Analytics: Delivers time-resolved physiological data enabling statistical comparison of neurochemical potency and duration of effect.
- Translational Research: Aligns with biomarker development efforts by linking ganglion activation to measurable autonomic outputs.
- Enterprise Reuse: Establishes a reusable surgical-injection platform for chronic or repeated vagal modulation studies across compound series.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic de-risking of vagal targets through direct neurochemical interrogation of nodose ganglia.
- Operational Value: Ensures reproducibility via standardized anesthesia, surgical exposure, and infusion parameters.
- Strategic Value: Improves target selection confidence by confirming physiological relevance before resource-intensive lead programs.
- Portfolio Impact: Enables early prioritization of compounds with desired vagal modulatory profiles, reducing investment in false positives.
Implementation Considerations
- Requires expertise in rodent microsurgery and vascular cannulation for femoral vein access.
- Dependent on precision glass syringes, polyethylene tubing, and piezo-electric strain gauge systems for respiratory monitoring.
- Necessitates standardized anesthesia protocols (ketamine-xylazine) and verification via toe-pinch reflex.
- Adaptation to other models may require adjustments in ganglion size, surgical approach, and infusion rates.
- Limited by operator skill in microinjection technique to avoid ganglion damage or leakage.
Biopharma FAQs
Why does isolating nodose ganglion injection matter for target validation?
Isolating injection to the nodose ganglion prevents central nervous system confounds, allowing attribution of physiological effects like apnea solely to vagal afferent modulation. This increases target validation confidence by confirming that observed responses originate from peripheral ganglion activity.
How does femoral vein catheterization support independent variable control in this procedure?
Femoral vein catheterization enables precise intravenous delivery of neurochemicals like serotonin to establish baseline apnea responses before ganglion injection. This controls for systemic variables, isolating the ganglion as the independent variable in subsequent tests.
What quantitative dependent variable measurements enable assessment of vagal modulation?
Respiratory signals are captured via piezo-electric strain gauge and amplified with high-pass (1 Hz) and low-pass (10 Hz) filters, sampled at 1000 Hz. Apnea is quantified as breathing pauses exceeding 2.5 seconds, providing a measurable dependent variable for neurochemical effect.
Why are replication requirements critical for cross-functional collaboration in vagal studies?
Replication ensures that apnea responses to serotonin or dronabinol are consistent across animals and experimenters, supporting reliable data transfer between discovery and preclinical teams. Standardized infusion rates (e.g., 12.5 µg/kg serotonin at 63 mL/hr) enable reproducible benchmarking.
What statistical analysis capabilities are required before implementing this method in a discovery pipeline?
Implementation requires the ability to compare pre- and post-injection respiratory signals using time-series analysis to detect significant changes in apnea frequency or duration. This supports statistical validation of neurochemical effects on vagal outflow prior to lead selection decisions.
Chapters in this video
0:05
Title
1:24
Preparation of Instruments and Chemicals
2:31
Catherization of the Femoral Vein
4:00
Serotonin–induced Apnea via IV Infusion
5:45
Neck Surgery to Expose Nodose Ganglia
8:18
Results: Respiratory Recordings after Serotonin Induction of Apnea Before and After Intranodose Ganglia Injections of Dronabinol
8:57
Conclusion
